Andrew S. Parker
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Surgery
- Endocrinology, Diabetes and Metabolism top 10%
- Pharmaceutical Science top 5%
- Co-authors
- Karl E. GriswoldChris Bailey‐KelloggStephen P. BeaudoinLynne S. TaylorYoonjoo ChoiJohn WelshDana E. MosesonTomas C. Walker
- Topics
- Monoclonal and Polyclonal Antibodies Research (6 papers)Drug Solubulity and Delivery Systems (5 papers)vaccines and immunoinformatics approaches (5 papers)
- Journals
- Proceedings of the National Academy of SciencesDiabetesCellular and Molecular Life Sciences
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Andrew S. Parker
23 papers receiving 469 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 199
- Radiology, Nuclear Medicine and Imaging 120
- Surgery 105
- Endocrinology, Diabetes and Metabolism 100
- Pharmaceutical Science 95
Countries citing papers authored by Andrew S. Parker
This map shows the geographic impact of Andrew S. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew S. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew S. Parker more than expected).
Fields of papers citing papers by Andrew S. Parker
This network shows the impact of papers produced by Andrew S. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew S. Parker. The network helps show where Andrew S. Parker may publish in the future.
Co-authorship network of co-authors of Andrew S. Parker
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew S. Parker. A scholar is included among the top collaborators of Andrew S. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew S. Parker. Andrew S. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 5 | |
| 3 | 54 | |
| 4 | 2 | |
| 5 | 58 | |
| 6 | 30 | |
| 7 | 16 | |
| 8 | 27 | |
| 9 | 25 | |
| 10 | 31 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 20 | |
| 14 | 24 | |
| 15 | 20 | |
| 16 | 2 | |
| 17 | 46 | |
| 18 | 23 | |
| 19 | 21 | |
| 20 | 41 |
About Andrew S. Parker
Andrew S. Parker is a scholar working on Pharmaceutical Science, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 483 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Drug Solubulity and Delivery Systems (5 papers) and vaccines and immunoinformatics approaches (5 papers). The work is most often cited by research in Pharmaceutical Science (95 citations), Biotechnology (58 citations) and Endocrinology, Diabetes and Metabolism (100 citations). Andrew S. Parker has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Karl E. Griswold, Chris Bailey‐Kellogg, Stephen P. Beaudoin, Lynne S. Taylor, Yoonjoo Choi, John Welsh, Dana E. Moseson, Tomas C. Walker, David A. Price and Wei Zheng. Their work appears in journals such as Proceedings of the National Academy of Sciences, Diabetes and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.